JULI, Giada
 Distribuzione geografica
Continente #
NA - Nord America 242
EU - Europa 232
AS - Asia 68
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 544
Nazione #
US - Stati Uniti d'America 239
IT - Italia 176
SG - Singapore 53
GB - Regno Unito 21
DE - Germania 10
FI - Finlandia 7
CN - Cina 6
HK - Hong Kong 6
FR - Francia 4
SE - Svezia 4
CA - Canada 3
NL - Olanda 3
EE - Estonia 2
ES - Italia 2
IN - India 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
BD - Bangladesh 1
BR - Brasile 1
CZ - Repubblica Ceca 1
UA - Ucraina 1
Totale 544
Città #
Chandler 47
Singapore 26
Ashburn 19
Catanzaro 19
Chicago 19
London 18
Santa Clara 18
Naples 13
Parma 10
Lawrence 8
Milan 8
Princeton 8
Rome 8
Helsinki 7
Catania 6
Hong Kong 6
San Nicola Manfredi 6
Santo Stefano di Rogliano 6
Los Angeles 5
Melito di Porto Salvo 5
Afragola 4
Brescia 4
Acquaviva delle Fonti 3
Aversa 3
Castrovillari 3
Hanover 3
Munich 3
Ottawa 3
Palermo 3
Redmond 3
San Antonio 3
Treviso 3
Wilmington 3
Agrigento 2
Assago 2
Boardman 2
Bologna 2
Campobello di Licata 2
Frankfurt am Main 2
Latina 2
New York 2
Paris 2
Romainville 2
Serra San Bruno 2
Settingiano 2
Sorrento 2
Vigliano Biellese 2
Washington 2
Ahmedabad 1
Arnhem 1
Bisignano 1
Buffalo 1
Des Moines 1
Dhaka 1
Fayetteville 1
Hyderabad 1
Kansas City 1
Madrid 1
Melito di Napoli 1
Mordano 1
Norwalk 1
Olomouc 1
Pachino 1
Phoenix 1
San Gennaro Vesuviano 1
Seattle 1
Secaucus 1
Soverato Marina 1
Squillace 1
São Paulo 1
Taranto 1
Vallefiorita 1
Totale 357
Nome #
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells 73
A drug repurposing screening reveals a novel epigenetic activity of hydroxychloroquine. 58
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 47
A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer 38
Bergamot Polyphenols Improve Dyslipidemia and Pathophysiological Features in a Mouse Model of Non-Alcoholic Fatty Liver Disease 38
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 36
Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma 35
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas 35
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin 33
Mir-22 modulates lenalidomide activity by counteracting myc addiction in multiple myeloma 29
Chromene Derivatives as Selective TERRA G-Quadruplex RNA Binders with Antiproliferative Properties 28
Oleil hydroxytyrosol (Htol) exerts anti-myeloma activity by antagonizing key survival pathways in malignant plasma cells 24
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 23
Therapeutic activation of G protein-coupled estrogen receptor 1 in Waldenström Macroglobulinemia 23
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma 22
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity 17
UMG1/CD3ε-bispecific T-cell engager redirects T-cell cytotoxicity against diffuse large B-cell lymphoma 9
Hit identification of novel small molecules interfering with MALAT1 triplex by a structure-based virtual screening 7
TERRA G-quadruplex stabilization behind the anti-multiple myeloma activity: Novel insights about resveratrol pleiotropic effects 5
Totale 580
Categoria #
all - tutte 6.231
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.231


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206 0 0 0 0 0 0 0 0 0 0 3 3
2020/202125 0 0 3 0 1 0 4 4 8 5 0 0
2021/202235 0 0 0 4 4 0 5 5 5 3 8 1
2022/2023191 22 14 17 8 16 10 2 12 21 27 41 1
2023/2024142 34 18 8 13 11 34 5 5 0 4 2 8
2024/2025174 30 3 4 6 25 46 16 17 23 4 0 0
Totale 580